Search Results 41-50 of 17262 for Irinotecan

  1. Small Bowel Cancer Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well ramucirumab and paclitaxel or the FOLFIRI regimen (leucovorin calcium, fluorouracil, and irinotecan hydrochloride) work ...

  2. Sotorasib (oral route) - Side effects & dosage - Mayo Clinic

    ... irinotecan) and whose tumors have an abnormal KRAS G12C gene. Your doctor will perform a genetic test before you use this medicine. Sotorasib belongs to the ...

  3. Bevacizumab-nwgd (intravenous route) - Mayo Clinic

    This medicine is also used in combination with other medicines (eg, fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin based chemotherapy) as ...

  4. MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) - Mayo Clinic

    To determine the RP2D of MEN1611 when administered orally in combination with cetuximab to patients with PIK3CA mutated colorectal cancer failing irinotecan, ...

  5. BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA) - Mayo Clinic

    ... irinotecan or topotecan at different doses. Irinotecan has already been approved by the FDA to treat pancreatic cancer while topotecan has already been ...

  6. Ramucirumab (intravenous route) - Side effects & uses - Mayo Clinic

    Ramucirumab injection is also used in combination with folinic acid, 5-fluorouracil, and irinotecan (FOLFIRI) to treat metastatic (cancer that has already ...

  7. Cancer Clinical Trials - Mayo Clinic Research

    Mayo Clinic will be pariticipating in Part B5, Sparse PK : ART0380 in combination with Irinotecan. A First-in-Human (FIH) Study to Evaluate the Safety and ...

  8. Cancer Treatment Clinical Trials - Mayo Clinic Research

    ... irinotecan or topotecan at different doses. Irinotecan has already been approved by the FDA to treat pancreatic cancer while topotecan has already been ...

  9. A Study of the Gut Microbiome in Chemotherapy Treatment - Mayo Clinic

    Receiving irinotecan for cancer treatment within 4 weeks of enrollment. Exclusion Criteria: Unable to provide informed consent. Vulnerable patients ...

  10. Clinical trials - Oncology (Medical)

    Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo ...